Corporate Profile for Advanced Viral Research Corp. Inc., dated June 23, 1995.MIAMI--(BUSINESS WIRE)--June 23, 1995--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and information services See Information Systems. . These include Dow Jones News/Retrieval, Bloomberg Financial Markets, Reuter Company Newsyear, Reuter Business Briefing, DataTimes, Nexis, Dialog, NewsNet, America OnLine, CompuServe, Delphi, Individual's HeadsUp and First!, Desktop Data's NewsEdge, UMI UMI University Microfilms International UMI United States Minor Outlying Islands (ISO Country code) UMI University of Miami UMI Universal Management Infrastructure (IBM) Data Courier, NewsBank, Information Access Company and many others. -0- Published date: June 23, 1995 Company name: Advanced Viral Research Corp. Inc.
Address: 848 Brickell Avenue, Suite No. 415
Miami, FL 33131
Telephone No.: 305/374-4847 Chief Executive Officer: Bernard Friedland Chief Financial Officer: William Bregman Investor Relations Contact: Mark Amster Business number: 305/374-4847 Home number: 305/432-8943 Public Relations Contact: Mark Amster Business number: 305/374-4847 Home number: 305/432-8943 Trading symbol: ADVR Industry: Biotechnology Market Makers: Bulletin Board Market Makers:
J ALEXANDER SECS INC LA; BAIRD PATRICK & CO NY;
CARR SECS CORP NY; CASTLE SECS CORP FREEPORT;
COASTAL SEC LTD DALLAS TX; FAHNESTOCK & CO INC NY;
WM V FRANKEL & CO J CY;
HILL THMPSN MAGID & CO J CY;
HERZOG HEINE GEDULD NY; INVESTORS ASSOCS HACK NJ
JOSEPHTHAL LYON & ROSS NY;
MAYER & SCHWEITZER INC J CY;
M H MEYERSON & CO INC J CY;
NAIB TRADING CORP FT LAUD;
PARAGON CAPTL CRP BCA RTN; TROSTER SINGER CORP J CY
WILSON-DAVIS & CO SLC; WIEN SECURITIES CORP J CY
Pink Sheet Market Makers:
JOSEPHTHAL LYON & ROSS NY
PARAGON CAPTL CRP BCA RTN
Company description: GENERAL: Advanced Viral Research Corp. Inc. (the "company") (BB:ADVR ADVR Association of Directors of Volunteer Resources (Canada) ), incorporated under the laws of the State of Delaware on July 31, 1985, was organized to engage in the production and marketing, promotion and sale of a non-toxic, anti-viral peptide-nucleic acid complex solution with the trade name RETICULOSE. RETICULOSE has not been approved by the U.S. Food and Drug Administration (the "FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. "). See "RETICULOSE." The company is in the developmental stage, and has not as yet commenced any material commercial operations. The company is dependent on registration of RETICULOSE in order to commence commercial operations. RETICULOSE: RETICULOSE had been marketed in the United States during the years 1940 through the early 1960's. While there have been no controlled clinical trials of RETICULOSE, the published data for the years 1951 through 1970, largely anecdotal, indicates that RETICULOSE is an anti-viral non-toxic pharmaceutical product which is effective in treating a number of interferon related viruses such as Asian Influenza Asian influenza n. Influenza that is caused by a strain of influenza virus type A, which was first isolated in China during the 1957 epidemic. , Viral Pneumonia viral pneumonia Pulmonology Pneumonia of viral origin, which is more severe in the very young and very old Common pathogens Adenovirus, influenza virus, parainfluenza virus, RSV, rhinovirus, HS, CMV. See Influenza, Pneumonia, Respiratory syncytial virus. , Virus Infectious Hepatitis infectious hepatitis n. Abbr. IH See hepatitis A. , Mumps Encephalitis encephalitis (ĕnsĕf'əlī`təs), general term used to describe a diffuse inflammation of the brain and spinal cord, usually of viral origin, often transmitted by mosquitoes, in contrast to a bacterial infection of the meninges , Herpes Simplex herpes simplex (hûr`pēz), an acute viral infection of the skin characterized by one or more painful, itching blisters filled with clear fluid. and Herpes Zoster. The company believes that RETICULOSE should be classified as an Immune System Modulator Modulator Any device or circuit by means of which a desired signal is impressed upon a higher-frequency periodic wave known as a carrier. The process is called modulation. The modulator may vary the amplitude, frequency, or phase of the carrier. . CONTACT: Advanced Viral Research, Miami William Bregman, 305/374-4847 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion